Company: BDRX
Filing Date: 2025-04-29
Form Type: POS AM
Source: 0001214659-25-006581
Chunk: 23

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-04-29
Form: POS AM
Chunk 23
---
 such
pending Purchase under the Purchase Agreement, and (ii) the Registration Rights Agreement, which shall survive any termination of the
Purchase Agreement. Further, no termination of the Purchase Agreement will be deemed to release us or the Selling Shareholder from any
liability for intentional misrepresentation or willful breach of the Purchase Agreement, the Registration Rights Agreement or any other
related transaction documents.

Dilutive Issuances and Purchase Price Adjustment

For as long as the Selling
Shareholder owns any of our Depositary Shares, if within three trading days immediately following a Purchase Date, we make certain issues
of our securities and such securities are issued at prices, or the New Issuance Price, less than the prices to be paid by the Selling
Shareholder in such Fixed Purchase, VWAP Purchase or Additional VWAP Purchase, the purchase price for such applicable Fixed Purchase,
VWAP Purchase or Additional VWAP Purchase would be reduced to the New Issuance Price, subject to the terms and conditions set forth in
the Purchase Agreement.

| 15 |

No Short-Selling or Hedging

The Selling Shareholder has
agreed that neither it nor any entity managed or controlled by it will engage in, directly or indirectly, any (A) “short sale”
(as such term is defined in Rule 200 of Regulation SHO of the Exchange Act) of our Depositary Shares or (B) hedging transaction, which,
with respect to items (A) and (B), establishes a net short position with respect to the Depositary Shares, during the term of the Purchase
Agreement. The Selling Shareholder has also agreed that neither it nor any entity managed or controlled by it will engage in or effect,
in any manner whatsoever, directly or indirectly, any “short sale” (as such term is defined in Rule 200 of Regulation SHO
of the Exchange Act) of our Depositary Shares.

Effect of Sales of our Depositary Shares under the Purchase Agreement on our Shareholders

The Depositary Shares being
registered for resale in this offering may be issued and sold by us to the Selling Shareholder from time to time at our discretion, during
the terms described above. The resale by the Selling Shareholder of a significant quantity of shares registered for resale in this offering
at any given time, or the perception that these sales may occur, could cause the market price of our Depositary Shares to decline and
to be highly volatile. Sales of our Depositary Shares, if any, to the Selling Share